Precure LLC has picked Helix to handle clinical whole genome and multiomics data from a million biospecimens. This marks a major step for precision medicine at Mayo Clinic and could reshape care across health systems.
A breakthrough in hornbill genomics offers scientists new tools to trace species history and guide conservation of four threatened Asian hornbills.
Phase III clinical trials now generate 5.9 million data points per protocol on average, with data volumes rising 11 percent annually since 2020 and operational models straining to keep pace.
Uzbekistan is moving ahead with a Biome center dedicated to cell technologies, genomics, and biobanking, aiming to strengthen its position in advanced bioscience research.
Researchers at Sidra Medicine have created a genomic method that combines genetic and brain imaging data to improve early prediction of cognitive decline, paving the way for more tailored brain health strategies.
MDU's Centre for Biotechnology brought leading scientists to campus to dissect how gene editing tools like CRISPR-Cas9 are reshaping malaria research and student training.
Researchers at ICAR-Central Rice Research Institute have shown that Plant OpenCRISPR-1, an AI-designed genome editor, works as well as established systems for editing rice genes.
British Ambassador Simon Walters is working to connect Israel with the Oxford-Cambridge Growth Corridor, aiming to build new partnerships in genomics, agri-tech, AI, and clean tech, even as political disagreements continue.
CAR-T therapy offers a lifeline for patients with relapsed blood cancers, but the real challenge is getting the treatment before time and logistics run out.
Artificial intelligence has crossed a threshold in biotechnology by designing functional viruses that target bacteria, opening vast opportunities and urgent responsibilities for India and the world.
Bristol Myers Squibb reports that its phase II QUINTESSENTIAL trial of arlocabtagene autoleucel met the main goal in adults with relapsed and refractory multiple myeloma.
A bold genetic rescue experiment led by UCF biologist Lauren Deaner has triggered unprecedented early breeding among translocated Florida scrub-jays, offering new hope for species recovery.
OpenAI claims a breakthrough on a Millennium Prize problem as billions flow into AI and researchers warn about the risks of runaway systems. Genomics projects show AI’s potential for medicine, even as the industry faces tough questions about safety and oversight.
BioCytics has brought in Eremid Genomic Services to run advanced single-cell transcriptomic and TCR sequencing on immune cells, aiming to speed up development of its autologous adaptive immune cell therapy for solid tumors.
Stanford researchers built a virtual biotech company powered by 37,000 AI agents, which quickly identified promising drug targets and independently suggested a cancer therapy later validated by a major pharmaceutical company.
North Carolina’s life sciences sector is taking a measured approach to growth, favoring smaller, risk-managed deals and targeted expansions, while a few major players make billion-dollar commitments.
LSUA has broken new ground with the first accredited 90 credit hour accelerated bachelor's degrees in bioinformatics and information technology, offering students a faster and more focused route into high-demand STEM fields.
Florida citrus growers are betting on gene edited rootstock to fight a bacterial disease that has decimated their groves and production.
